US-based implants maker RTI Surgical has launched a new technology to offer surgeons with three-dimensional (3D) printed polymer implant material for spinal interbody fusion.

The new TETRAfuse 3D Technology is said to provide trabecular bone ingrowth with simultaneous maintenance of radiolucency and mechanical properties similar to a bone.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

TETRAfuse 3D printing process is designed to create a nano-rough surface on the whole implant to allow bony ingrowth across the disc space from endplate to endplate for deep implant osseointegration.

RTI Surgical CEO Camille Farhat said: “We are excited about the promise this technology holds for our surgeon customers and their patients.

“Being the first to offer surgeons a 3D printed interbody polymer optimised to participate in fusion marks another significant milestone for RTI in our quest to continuously deliver relevant and innovative products without compromise.”

“Being the first to offer surgeons a 3D printed interbody polymer optimised to participate in fusion marks a significant milestone.”

The ability of the new technology to combine fusion process, bone-like mechanical properties and radiolucent imaging is intended to provide surgeons with the osseointegrative advantages of both titanium and allograft bone, along with the benefits of PEEK.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

RTI Surgical is planning to manufacture a variety of products and derivative offerings using its new TETRAfuse 3D Technology.

With four manufacturing plants in the US and Europe, the firm primarily focuses on providing safe biologic, metal and synthetic implants to surgeons.

The firm’s portfolio of sports medicine, general surgery, spine, orthopaedic, trauma and cardiothoracic implants are available in approximately 50 countries.